ArticleTransplantation direct2020

Efficacy and Safety of Tocilizumab in the Treatment of Acute Active Antibody-mediated Rejection in Kidney Transplant Recipients.

April A Pottebaum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.